Rao J S, Ertley R N, Lee H-J, DeMar J C, Arnold J T, Rapoport S I, Bazinet R P
Brain Physiology and Metabolism Section, National Institute on Aging, National Institutes of Health, Bethesda, MD 20892, USA.
Mol Psychiatry. 2007 Jan;12(1):36-46. doi: 10.1038/sj.mp.4001888. Epub 2006 Sep 19.
Decreased docosahexaenoic acid (DHA) and brain-derived neurotrophic factor (BDNF) have been implicated in bipolar disorder. It also has been reported that dietary deprivation of n-3 polyunsaturated fatty acids (PUFAs) for 15 weeks in rats, increased their depression and aggression scores. Here, we show that n-3 PUFA deprivation for 15 weeks decreased the frontal cortex DHA level and reduced frontal cortex BDNF expression, cAMP response element binding protein (CREB) transcription factor activity and p38 mitogen-activated protein kinase (MAPK) activity. Activities of other CREB activating protein kinases were not significantly changed. The addition of DHA to rat primary cortical astrocytes in vitro, induced BDNF protein expression and this was blocked by a p38 MAPK inhibitor. DHA's ability to regulate BDNF via a p38 MAPK-dependent mechanism may contribute to its therapeutic efficacy in brain diseases having disordered cell survival and neuroplasticity.
二十二碳六烯酸(DHA)和脑源性神经营养因子(BDNF)水平降低与双相情感障碍有关。据报道,大鼠饮食中缺乏n-3多不饱和脂肪酸(PUFA)15周后,其抑郁和攻击得分会增加。在此,我们发现,缺乏n-3 PUFA 15周会降低额叶皮质DHA水平,并减少额叶皮质BDNF表达、cAMP反应元件结合蛋白(CREB)转录因子活性和p38丝裂原活化蛋白激酶(MAPK)活性。其他CREB激活蛋白激酶的活性没有显著变化。在体外向大鼠原代皮质星形胶质细胞中添加DHA可诱导BDNF蛋白表达,而这一过程被p38 MAPK抑制剂阻断。DHA通过p38 MAPK依赖性机制调节BDNF的能力可能有助于其在具有细胞存活紊乱和神经可塑性的脑部疾病中的治疗效果。